已发表的诊断模型在独立初级保健验证研究中能安全排除结直肠癌
该研究在810例荷兰初级保健因持续下腹部症状转诊内镜检查的患者中,独立验证了18个已发表诊断模型。针对结直肠癌(37例),最佳模型NICE-1可安全排除59%的转诊,灵敏度96%,阴性预测值100%,AUC 0.86。针对显著结直肠疾病(141例),最佳模型Brazer仅排除23%的转诊,AUC 0.73。
要点
- 在810例荷兰初级保健转诊内镜患者中验证了18个已发表诊断模型。
- NICE-1模型排除59%的转诊,结直肠癌灵敏度96%,阴性预测值100%。
- 针对显著结直肠疾病,最佳模型Brazer仅排除23%的转诊,AUC 0.73。
核心结论
- 多数模型能在许多因下消化道症状转诊内镜的初级保健患者中安全排除结直肠癌,但对显著结直肠疾病的排除表现较差。
研究设计与样本
- 系统文献检索后,在810例荷兰初级保健持续下腹部症状转诊内镜患者中开展横断面研究,独立验证已识别诊断模型。
主要发现
- 共评估18个模型,其中12个为结直肠癌特异性模型,多数能安全排除结直肠癌。
- 最佳模型NICE-1排除59%的转诊(95%CI 56-63%),结直肠癌灵敏度96%(95%CI 83-100%),阴性预测值100%(95%CI 99-100%),AUC 0.86(95%CI 0.80-0.92)。
- 针对显著结直肠疾病(141例,包括结直肠癌、炎症性肠病、憩室炎或>1cm腺瘤),最佳模型Brazer排除23%的转诊(95%CI 20-26%),灵敏度95%(95%CI 90-98%),阴性预测值96%(95%CI 92-98%),AUC 0.73(95%CI 0.69-0.78)。
关键数值与推荐
- NICE-1模型:排除59%的转诊(95%CI 56-63%),结直肠癌灵敏度96%(95%CI 83-100%),阴性预测值100%(95%CI 99-100%),AUC 0.86(95%CI 0.80-0.92)。
- Brazer模型:排除23%的转诊(95%CI 20-26%),显著结直肠疾病灵敏度95%(95%CI 90-98%),阴性预测值96%(95%CI 92-98%),AUC 0.73(95%CI 0.69-0.78)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To validate published diagnostic models for their ability to safely reduce unnecessary endoscopy referrals in primary care patients suspected of significant colorectal disease. STUDY DESIGN AND SETTING: Following a systematic literature search, we independently validated the identified diagnostic models in a cross-sectional study of 810 Dutch primary care patients with persistent lower abdominal complaints referred for endoscopy. We estimated diagnostic accuracy measures for colorectal cancer (N = 37) and significant colorectal disease (N = 141; including colorectal cancer, inflammatory bowel disease, diverticulitis, or >1-cm adenomas). RESULTS: We evaluated 18 models-12 specific for colorectal cancer-, of which most were able to safely rule out colorectal cancer: the best model (National Institute for Health and Care Excellence-1) prevented 59% of referrals (95% confidence interval [CI]: 56-63%), with 96% sensitivity (95% CI: 83-100%), 100% negative predictive value (NPV; 95% CI: 99-100%), and an area under the receiver operating characteristics curve (AUC) of 0.86 (95% CI: 0.80-0.92). The models performed less for significant colorectal disease: the best model (Brazer) prevented 23% of referrals (95% CI: 20-26%), with 95% sensitivity (95% CI: 90-98%), 96% NPV (95% CI: 92-98%), and an AUC of 0.73 (95% CI: 0.69-0.78). CONCLUSION: Most models safely excluded colorectal cancer in many primary care patients with lower gastrointestinal complaints referred for endoscopy. Models performed less well for significant colorectal disease.
引用
- Elias SG, Kok L, Witteman BJM, et al. Published diagnostic models safely excluded colorectal cancer in an independent primary care validation study. J Clin Epidemiol. 2016. PMID: 27989951. doi:10.1016/j.jclinepi.2016.09.014
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。